Clinical Trials
14
Active:0
Completed:12
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)
Completed
- Conditions
- Arterial HypertensionHTN
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Servier Russia
- Target Recruit Count
- 396
- Registration Number
- NCT06259175
- Locations
- 🇷🇺
Servier, Moscow, Russian Federation
Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia (TARGET)
Completed
- Conditions
- Arterial HypertensionHTN
- First Posted Date
- 2023-03-10
- Last Posted Date
- 2024-04-19
- Lead Sponsor
- Servier Russia
- Target Recruit Count
- 409
- Registration Number
- NCT05764317
- Locations
- 🇷🇺
Servier, Moscow, Russian Federation
Evaluation of the AIVARIX in Detecting Signs C 1-2 Classes of CVD
Not yet recruiting
- Conditions
- CVDChronic Venous Disease
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2022-11-10
- Lead Sponsor
- Servier Russia
- Target Recruit Count
- 414
- Registration Number
- NCT05612217
- Locations
- 🇷🇺
Pirogov Russian National Research Medical University, Moscow, Russian Federation
Effectiveness and Tolerability of аgomelatine in the Treatment of Patients With Depression After SARS-CoV-2 (TELESPHOR)
Completed
- Conditions
- DepressionCOVID-19
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Servier Russia
- Target Recruit Count
- 104
- Registration Number
- NCT05323994
- Locations
- 🇷🇺
Federal State Autonomous Educational Institution of Higher Education "Peoples' Friendship University of Russia", Moscow, Russian Federation
Objective Confirmation of thе Anti-ischemic Effectiveness of Trimetazidine 80mg Once Daily in Patients With Stable Angina Who Had a History of Myocardial Infarction (METHOD)
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2024-04-18
- Lead Sponsor
- Servier Russia
- Target Recruit Count
- 36
- Registration Number
- NCT05210465
- Locations
- 🇷🇺
"Institute for Complex Issues of Cardiovascular Diseases", Kemerovo, Russian Federation
🇷🇺Barbarash Olga Leonidovna, Moscow, Russian Federation
- Prev
- 1
- 2
- 3
- Next
News
No news found